Immunotherapy for Cancer Patients With Autoimmune Diseases

In 2019, the National Cancer Institute (NCI) revealed that a group of researchers has launched a clinical trial to examine an immunotherapy drug in patients who have been diagnosed with both cancer and autoimmune diseases, such as lupus, rheumatoid arthritis, or type 1 diabetes.

Immunotherapy drugs improve the ability of the immune system to recognize and attack tumor cells. In recent years, immunotherapy treatments have benefited a growing number of men and women, including patients with advanced cancers.

However, doctors have not uncovered whether immunotherapy is completely safe and effective for those who have both an autoimmune disease and cancer …read more